UZH-Logo

No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam


Tomalik-Scharte, D; Doroshyenko, O; Kirchheiner, J; Jetter, A; Lazar, A; Klaassen, T; Frank, D; Wyen, C; Fätkenheuer, G; Fuhr, U (2008). No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam. European Journal of Clinical Pharmacology, 64(10):1033-1035.

Citations

13 citations in Web of Science®
15 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

126 downloads since deposited on 28 Nov 2008
28 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:October 2008
Deposited On:28 Nov 2008 16:47
Last Modified:05 Apr 2016 12:36
Publisher:Springer
ISSN:0031-6970
Additional Information:The original publication is available at www.springerlink.com
Publisher DOI:10.1007/s00228-008-0503-9
PubMed ID:18587567
Permanent URL: http://doi.org/10.5167/uzh-6211

Download

[img]
Preview
Content: Accepted Version
Filetype: PDF
Size: 996kB
View at publisher
Licence: Creative Commons: Attribution 3.0 Unported (CC BY 3.0)

Author Collaborations